OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
12
Results
Show all
Save search
Copy query
Show results for
Unknown
(12)
Publication Date
Release Date
2025
(2)
2023
(2)
2021
(2)
2024
(1)
2022
(1)
2019
(1)
2018
(1)
2016
(1)
2015
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Treatment of severe cow's milk allergy with omalizumab in an adult.
Not available
S-EPMC9904097
|
biostudies-literature
Cite
Atopic Multimorbidity in Adults With a Focus on Sensitization Patterns and T Cell Activation.
Not available
S-EPMC12661119
|
biostudies-literature
Cite
Heat Treatment of Hazelnut Allergens Monitored by Polyclonal Sera and Epitope Fingerprinting.
Not available
S-EPMC11640838
|
biostudies-literature
Cite
Dichotomous STAT5 and STAT6 Activation in T Cells Reflects Cytokine Shifts Between Blood and Skin in Atopic Dermatitis.
Not available
S-EPMC12368756
|
biostudies-literature
Cite
Anaphylaxis in Elderly Patients-Data From the European Anaphylaxis Registry.
Not available
S-EPMC6491699
|
biostudies-literature
Cite
Identification and Purification of Novel Low-Molecular-Weight Lupine Allergens as Components for Personalized Diagnostics.
Not available
S-EPMC7911308
|
biostudies-literature
Cite
Folded or Not? Tracking Bet v 1 Conformation in Recombinant Allergen Preparations.
Not available
S-EPMC4506129
|
biostudies-literature
Cite
Standardization of double blind placebo controlled food challenge with soy within a multicentre trial.
Not available
S-EPMC5098282
|
biostudies-literature
Cite
Management of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hypersensitivity.
Not available
S-EPMC9350006
|
biostudies-literature
Cite
Meat allergy associated with galactosyl-α-(1,3)-galactose (α-Gal)-Closing diagnostic gaps by anti-α-Gal IgE immune profiling.
Not available
S-EPMC7254904
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets